[Primary and secondary failure of sulphonylureas].
Kanno
Hiroko
H
Diabetes Center, Tokyo Women's Medical University.
Sakura
Hiroshi
H
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000375:Aging / Q000502:physiology; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000628:therapy*; D003927:Diet, Diabetic; D004232:Diuretics / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005081:Exercise Therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D013256:Steroids; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017211:Treatment Failure
D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D004232:Diuretics; D007004:Hypoglycemic Agents; D007328:Insulin; D013256:Steroids; D013453:Sulfonylurea Compounds